Having established that PPM1D-knockdown reduces tumor formation in mice and that gain of chromosome 17q harboring PPM1D is a strong prognostic factor for poor survival in both neuroblastoma and medulloblastoma [45,46], we next investigated the effects of compounds inhibiting WIP1 activity in both cancers. Here, PPM1D is linked to neuroblastoma.